Prediction of Hospital Mortality in Patients with ST Segment Elevation Myocardial Infarction: Evolution of Risk

B I Geltser1, I G Domzhalov2, K I Shakhgeldyan3

  • 1MD, DSc, Professor, Corresponding Member of the Russian Academy of Science, Deputy Director for Science of the School of Medicine and Life Sciences; Far Eastern Federal University, 10 Village Ayaks, Island Russkiy, Vladivostok, 690922, Russia.

PubMed

Insights

Predicting hospital mortality in ST-segment elevation myocardial infarction (STEMI) is crucial. This review compares traditional scales with new machine learning tools for better risk stratification.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Biostatistics

Background:

  • Risk stratification for hospital mortality in ST-segment elevation myocardial infarction (STEMI) is vital for patient care.
  • Existing prognostic scales (GRACE, CADILLAC, TIMI) are widely used but may lack precision.
  • The search for novel predictors and advanced risk assessment tools is ongoing.

Purpose of the Study:

  • To systematically review and compare the predictive value of classical prognostic scales and novel machine learning-based risk tools for hospital mortality in STEMI patients.
  • To highlight the importance of developing explainable artificial intelligence (AI) algorithms for clinical trust.

Main Methods:

  • Systematic literature review of scientific data.
  • Analysis of studies evaluating classical prognostic scales (e.g., GRACE, CADILLAC, TIMI risk score for STEMI, RECORD).
  • Evaluation of new risk measurement tools based on machine learning techniques.

Main Results:

  • Classical prognostic scales offer established risk stratification for STEMI patients.
  • Emerging machine learning techniques show potential for more detailed and accurate risk prediction.
  • Studies increasingly focus on identifying new predictors to refine patient status-to-outcome relationships.

Conclusions:

  • Both traditional scales and machine learning tools play a role in STEMI mortality risk stratification.
  • Developing explainable AI prognostic algorithms is essential for clinical adoption and trust.
  • Further research is needed to integrate advanced AI tools into routine clinical practice for improved patient outcomes.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...